Groups | n | IL-10 levels | IL-12 levels | IFN-γ levels | |||
---|---|---|---|---|---|---|---|
Day 7 (ratio,%) | Day 14 (ratio,%) | Day 7 (ratio,%) | Day 14 (ratio,%) | Day 7 (ratio,%) | Day 14 (ratio,%) | ||
Control | 6 | 190.9 ± 53.0 | 257.4 ± 65.4 | 18.1 ± 4.3 | 17.4 ± 2.0 | 201.9 ± 39.7 | 184.9 ± 31.6 |
CFRT* | 6 | 155.3 ± 48.8 (−↓18.6△) | 219.9 ± 54.1 (− 14.6△) | 21.7 ± 2.5# (+↑19.9△) | 19.1 ± 1.9 (+ 9.8△) | 222.2 ± 38.8 (+ 10.1△) | 210.8 ± 36.1 (+ 14.0△) |
SBHFRTҰ | 6 | 91.6 ± 31.5#※ (− 52.0△ /− 41.0▼) | 135.8 ± 47.6#※ (− 47.2△ /− 38.2▼) | 26.8 ± 2.8#※ (+ 48.1△ /+ 23.5▼) | 22.5 ± 2.5#※ (+ 29.3△ /+ 17.8▼) | 348.4 ± 53.9#※ (+ 72.6△ /+ 56.8▼) | 270.7 ± 44.6#※ (+ 46.4△ /+ 28.4▼) |
F | 7.38 | 7.38 | 19.68 | 8.70 | 18.94 | 8.11 | |
P | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |